Dr. Gladys Linda Giron, MD

Dr. Giron practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Giron's NPI, 1003034760, was assigned on April 20, 2007. Dr. Giron graduated from University of Miami, Miller School of Medicine in 1995. Dr. Giron holds Florida license ME72398.

Dr. Giron's primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Dr. Giron's primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. Dr. Giron is also affiliated with South Miami Hospital. The medical group on file is Baptist Health Medical Group. Dmand AI also links Dr. Giron to 1 more hospital and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Giron practices, 4 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Giron's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Giron is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Giron's licenses on file in 2 states: Florida and New York.

Dmand AI lists mastectomy among the conditions Dr. Giron treats.

CMS data shows 129 Medicare services from Dr. Giron across 7 procedure codes in 2024, for 85 Medicare patients. Medicare paid $20,987 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 85 Medicare patients who saw Dr. Giron in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have cancer, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Giron's median patient age at 62, with 98% women.

In 2024, Dr. Giron wrote 28 Medicare Part D claims for 20 patients. 96% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $150 in total drug cost. In 2017, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Giron for performance year 2024, reported through an alternative payment model (APM). Dr. Giron accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Giron as offering telehealth. CMS counts 26 procedures of mastectomy by Dr. Giron, more than 84% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Giron, published from 2006 to 2015. The most frequent topics are Breast Neoplasms, Axilla and Biopsy, Needle. Dr. Giron has published most often in Am Surg. Dr. Giron's most frequent co-authors are Jane E. Mendez, MD, Eli Avisar, MD and Edi Brogi, MD.

CMS Open Payments shows 15 general payments to Dr. Giron from 3 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 91% of the total. Musculoskeletal Transplant Foundation Inc. paid the most, $946.

Dmand AI lists 1 award for Dr. Giron. Dr. Giron serves on Breast Disease Management Team Miami Cancer Institute.

Dr. Giron graduated from University of Miami, Miller School of Medicine in 1995. Dr. Giron is a member of ACS and ASCO.

Dr. Giron is in network with 10 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.